All In Biotech

Free tool

FAERS Monitor: Tpn Electrolytes In Plastic Container

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 018895 or its brand name (Tpn Electrolytes In Plastic Container, Calcium Chloride, Magnesium Chloride, Potassium Chloride, Sodium Acetate, Sodium Chloride). Reports on generic versions are filed under their own applications.

Reports

35

Serious

29

83% of reports

Hospitalization

16

Death reported

6

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea4
  • vomiting4
  • urticaria3
  • cough2
  • covid-192
  • death2
  • fungaemia2
  • hepatic failure2
  • pruritus2
  • sepsis2
  • urinary tract infection2
  • abdominal abscess1
  • abdominal pain1
  • abdominal pain upper1
  • acquired aminoaciduria1

Reports by year received

View as table
YearReports
20051
20101
20121
20141
20153
20183
20194
20202
20214
20225
20233
20243
20251
20262

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,124 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
acquired aminoaciduria115038.72125.83,667
fungaemia2764.8198.9856
abdominal abscess1136.019.733
hepatic failure239.910.442
sepsis210.82.89
urticariaSignal310.83.618
urinary tract infection27.01.85
covid-1926.91.85
vomitingSignal45.12.010
cough24.31.12
pruritus23.10.81
nausea43.01.24
abdominal pain upper12.90.40
abdominal pain12.60.40
death21.40.40

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.